{"id":"https://openalex.org/W4409463590","doi":"https://doi.org/10.2147/bctt.s499373","title":"Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil","display_name":"Unveiling the Landscape of PD-L1 Expression and Tumor-Infiltrating Lymphocyte Subtypes in Advanced Triple-Negative Breast Cancer in Brazil","publication_year":2025,"publication_date":"2025-04-01","ids":{"openalex":"https://openalex.org/W4409463590","doi":"https://doi.org/10.2147/bctt.s499373","pmid":"https://pubmed.ncbi.nlm.nih.gov/40256247"},"language":"en","primary_location":{"id":"doi:10.2147/bctt.s499373","doi":"https://doi.org/10.2147/bctt.s499373","is_oa":true,"landing_page_url":"https://doi.org/10.2147/bctt.s499373","pdf_url":null,"source":{"id":"https://openalex.org/S4210232997","display_name":"Breast Cancer Targets and Therapy","issn_l":"1179-1314","issn":["1179-1314"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer: Targets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.2147/bctt.s499373","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021953629","display_name":"Alexssandra Lima Siqueira dos Santos","orcid":"https://orcid.org/0000-0001-8851-9816","observed_orcids":["https://orcid.org/0000-0001-8851-9816"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Alexssandra Dos Santos","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489295","display_name":"Jess\u00e9 Lopes da Silva","orcid":"https://orcid.org/0000-0002-0790-9917","observed_orcids":["https://orcid.org/0000-0002-0790-9917"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jesse Da Silva","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021816204","display_name":"Lucas Zanetti de Albuquerque","orcid":"https://orcid.org/0000-0003-4945-1788","observed_orcids":["https://orcid.org/0000-0003-4945-1788"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Lucas De Albuquerque","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108319638","display_name":"Ant\u00f4nio Lucas Ara\u00fajo Neto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ant\u00f4nio Lucas Neto","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111187034","display_name":"Cec\u00edlia Ferreira da Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Cec\u00edlia Da Silva","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114156265","display_name":"Luana Aguiar Mesquita Cerva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Luana Cerva","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041119043","display_name":"Isabele Avila Small","orcid":"https://orcid.org/0000-0003-0598-9295","observed_orcids":["https://orcid.org/0000-0003-0598-9295"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Isabele Small","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054130714","display_name":"Fabiana Resende Rodrigues","orcid":"https://orcid.org/0000-0001-5062-1065","observed_orcids":["https://orcid.org/0000-0001-5062-1065"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fabiana Rodrigues","raw_affiliation_strings":["Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042328216","display_name":"Fabiane Carvalho de Macedo","orcid":"https://orcid.org/0000-0002-8359-7564","observed_orcids":["https://orcid.org/0000-0002-8359-7564"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fabiane De Macedo","raw_affiliation_strings":["Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045591148","display_name":"C\u00edcera Pimenta Marcelino","orcid":"https://orcid.org/0000-0003-3531-4934","observed_orcids":["https://orcid.org/0000-0003-3531-4934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cicera Marcelino","raw_affiliation_strings":["MSD Brazil, S\u00e3o Paulo, Brazil"],"raw_orcid":"https://orcid.org/0000-0003-3531-4934","affiliations":[{"raw_affiliation_string":"MSD Brazil, S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066461049","display_name":"Paula de Mendon\u00e7a Batista","orcid":"https://orcid.org/0000-0001-6860-1740","observed_orcids":["https://orcid.org/0000-0001-6860-1740"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula Batista","raw_affiliation_strings":["MSD Brazil, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD Brazil, S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015050722","display_name":"Maria Aparecida do Carmo Rego","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Aparecida Rego","raw_affiliation_strings":["MSD Brazil, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD Brazil, S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112499408","display_name":"Maria Am\u00e9lia Carlos Souto Maior Borba","orcid":"https://orcid.org/0000-0002-8051-0953","observed_orcids":["https://orcid.org/0000-0002-8051-0953"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Am\u00e9lia Borba","raw_affiliation_strings":["MSD Brazil, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD Brazil, S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031354838","display_name":"Andr\u00e9ia Cristina de Melo","orcid":"https://orcid.org/0000-0002-1201-4333","observed_orcids":["https://orcid.org/0000-0002-1201-4333"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Andreia De Melo","raw_affiliation_strings":["Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-1201-4333","affiliations":[{"raw_affiliation_string":"Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":1.4899,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.82680233,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"Volume 17","issue":null,"first_page":"349","last_page":"358"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8047000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8047000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.19300000369548798,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9570000171661377},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9679999947547913},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.7409999966621399},{"id":"https://openalex.org/keywords/combined-positive-score","display_name":"combined positive score","score":0.777999997138977},{"id":"https://openalex.org/keywords/cd3-t-cells","display_name":"CD3+ T cells","score":0.6290000081062317},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6790000200271606},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8989999890327454},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8149999976158142},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.6686455607414246},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5286881327629089},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4740302860736847},{"id":"https://openalex.org/C90559484","wikidata":"https://www.wikidata.org/wiki/Q778379","display_name":"Expression (computer science)","level":2,"score":0.45224273204803467},{"id":"https://openalex.org/C2992734768","wikidata":"https://www.wikidata.org/wiki/Q48964","display_name":"Triple negative","level":4,"score":0.45016273856163025},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.44790056347846985},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.4398096203804016},{"id":"https://openalex.org/C2986637895","wikidata":"https://www.wikidata.org/wiki/Q953865","display_name":"Breast tumor","level":4,"score":0.4338175058364868},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3934776782989502},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3801172077655792},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36998462677001953},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34593990445137024},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3455621600151062},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2692021131515503},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.17133912444114685},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.2147/bctt.s499373","doi":"https://doi.org/10.2147/bctt.s499373","is_oa":true,"landing_page_url":"https://doi.org/10.2147/bctt.s499373","pdf_url":null,"source":{"id":"https://openalex.org/S4210232997","display_name":"Breast Cancer Targets and Therapy","issn_l":"1179-1314","issn":["1179-1314"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer: Targets and Therapy","raw_type":"journal-article"},{"id":"pmid:40256247","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40256247","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer (Dove Medical Press)","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/102125","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/unveiling-the-landscape-of-pd-l1-expression-and-tumor-infiltrating-lym-peer-reviewed-fulltext-article-BCTT","pdf_url":"https://www.dovepress.com/article/download/102125","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12009053","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12009053","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Breast Cancer (Dove Med Press)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.2147/bctt.s499373","doi":"https://doi.org/10.2147/bctt.s499373","is_oa":true,"landing_page_url":"https://doi.org/10.2147/bctt.s499373","pdf_url":null,"source":{"id":"https://openalex.org/S4210232997","display_name":"Breast Cancer Targets and Therapy","issn_l":"1179-1314","issn":["1179-1314"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.699999988079071,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064898491","https://openalex.org/W2592049401","https://openalex.org/W2387231244","https://openalex.org/W2117189145","https://openalex.org/W2156193942","https://openalex.org/W3203000403","https://openalex.org/W3151231688","https://openalex.org/W4250415846","https://openalex.org/W2254963647","https://openalex.org/W2356671061"],"abstract_inverted_index":{"Purpose:":[0],"This":[1,201],"study":[2,97,202],"aimed":[3],"to":[4,38],"assess":[5],"the":[6,74,81,206],"frequency":[7],"and":[8,19,31,54,80,119,142,158,173,211],"prognostic":[9],"significance":[10],"of":[11,105,110,128,155,197,209],"programmed":[12],"cell":[13],"death":[14],"ligand":[15],"1":[16],"(PD-L1)":[17],"expression":[18,70,154,207],"tumor-infiltrating":[20],"lymphocyte":[21],"(TIL)":[22],"subtypes":[23,89,213],"in":[24,126,131,139,182,194,214,229],"advanced":[25,215],"triple-negative":[26],"breast":[27],"cancer":[28],"(TNBC).":[29],"Patients":[30],"Methods:":[32],"A":[33],"database":[34],"search":[35],"was":[36,71,86,124],"conducted":[37],"identify":[39],"women":[40],"with":[41,101,149,167],"previously":[42],"untreated":[43],"locally":[44],"recurrent":[45],"inoperable":[46],"or":[47,187],"metastatic":[48,121],"TNBC":[49],"treated":[50],"between":[51],"January":[52],"2018":[53],"December":[55],"2022.":[56],"The":[57,96,108,217],"inclusion":[58],"criteria":[59],"required":[60],"formalin-fixed":[61],"paraffin-embedded":[62],"samples":[63],"aged":[64],"less":[65],"than":[66,114],"four":[67],"years.":[68,107],"PD-L1":[69,75,146,150,192,210,218,237],"evaluated":[72],"using":[73,92],"IHC":[76],"22C3":[77],"pharmDx":[78],"assay,":[79],"combined":[82],"positive":[83],"score":[84],"(CPS)":[85],"calculated.":[87],"TIL":[88,160,212,230],"were":[90,112,137,180,233],"assessed":[91],"immunohistochemical":[93],"staining.":[94],"Results:":[95],"included":[98],"150":[99],"patients,":[100],"a":[102],"median":[103,183],"age":[104],"51.5":[106],"majority":[109],"patients":[111,163],"younger":[113],"65":[115],"years,":[116],"postmenopausal,":[117],"non-white,":[118],"had":[120,152],"TNBC.":[122,216],"CPS\u226510":[123,151],"observed":[125,181,234],"20.9%":[127],"cases,":[129],"mainly":[130],"postmenopausal":[132],"women.":[133],"No":[134,176],"significant":[135,178],"differences":[136,179],"found":[138],"demographic":[140],"characteristics":[141],"clinicopathological":[143],"variables":[144],"across":[145,191],"subgroups.":[147],"Tumors":[148],"higher":[153],"CD3+,":[156],"CD4+,":[157],"CD8+":[159],"subtypes.":[161],"Most":[162],"received":[164],"first-line":[165],"chemotherapy,":[166],"smaller":[168],"proportions":[169],"undergoing":[170],"second,":[171],"third,":[172],"fourth-line":[174],"treatments.":[175],"statistically":[177],"progression-free":[184],"survival":[185,189,225],"(PFS)":[186],"overall":[188],"(OS)":[190],"subgroups":[193],"this":[195],"cohort":[196],"chemotherapy-treated":[198],"patients.":[199],"Conclusion:":[200],"provides":[203],"insights":[204],"into":[205],"profiles":[208],"CPS":[219,238],"status":[220],"did":[221],"not":[222],"significantly":[223],"affect":[224],"outcomes,":[226],"but":[227],"variations":[228],"subtype":[231],"composition":[232],"based":[235],"on":[236],"status.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":4}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}